Lecanemab
Lecanemab
Immunoglobulin G1, anti-(human beta-amyloid protofibril) (human-Mus musculus monoclonal BAN2401 heavy chain), disulfide with human-Mus musculus monoclonal BAN2401 light chain, dimer
Stoffgruppe
Antidementivum
Halbwertszeit
5-7 d